/BRAXF
BRAXF Stock - Braxia Scientific Corp.
Healthcare|BiotechnologyOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.54
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.65
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BRAXF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.38
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Revenue | $1.88M | $1.49M | $1.01M | $212 |
| Gross Profit | $171,743 | $-3,281,532 | $-2,891,024 | $-8,946 |
| Gross Margin | 9.1% | -220.7% | -286.7% | -4219.8% |
| Operating Income | $-7,480,135 | $-7,159,370 | $-10,541,548 | $-172,470 |
| Net Income | $-13,141,704 | $-12,134,091 | $-88,828,146 | $-172,723 |
| Net Margin | -697.5% | -815.9% | -8809.1% | -81473.1% |
| EPS | $-0.06 | $-0.07 | $-0.56 | $-0.00 |
Company Overview
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. It is also involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and developing ketamine and psilocybin derivatives and other psychedelic products from its IP development platform. In addition, the company owns and operates multidisciplinary clinics for the treatment of mental health disorders. Braxia Scientific Corp. is headquartered in Mississauga, Ontario.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BRAXFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q1 2024
EPS Surprise History
Q1 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q1 23
No data
Q3 23
No data
Q4 23
No data
Q1 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Mar 17, 2025 | — | — | — | — |
Q1 2025 | Feb 26, 2025 | — | — | — | — |
Q4 2024 | Nov 27, 2024 | — | — | — | — |
Q3 2024 | Aug 29, 2024 | — | — | — | — |
Q1 2024 | Mar 1, 2024 | — | — | — | — |
Q1 2024 | Feb 29, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 29, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 29, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 1, 2023 | — | $-0.02 | — | — |
Q1 2023 | Feb 27, 2023 | — | $-0.01 | — | — |
Q4 2022 | Nov 29, 2022 | — | $-0.01 | — | — |
Q3 2022 | Aug 29, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 1, 2022 | — | $-0.03 | — | — |
Q4 2021 | Dec 11, 2021 | — | $-0.01 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.01 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.01 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.57 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BRAXF
What is BRAXF's current stock price?
Braxia Scientific Corp. (BRAXF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for BRAXF?
No analyst price targets are currently available for this stock.
What sector is Braxia Scientific Corp. in?
Braxia Scientific Corp. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is BRAXF's market cap?
Braxia Scientific Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does BRAXF pay dividends?
No, Braxia Scientific Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACBM
Acro Biomedical Co., Ltd.
$0.00
Mkt Cap: $0.0B
ARYC
Arrayit Corporation
$0.00
Mkt Cap: $0.0B
AVXT
AVAX Technologies, Inc.
$0.00
Mkt Cap: $0.0B
DNAG
DNAPrint Genomics, Inc.
$0.00
Mkt Cap: $0.0B
EHOS
Ehouse Global, Inc.
$0.00
Mkt Cap: $0.0B
MOBO
Mobile Lads Corp.
$0.00
Mkt Cap: $0.0B
PBLA
Panbela Therapeutics, Inc.
$0.00
Mkt Cap: $0.0B
TRCNF
Transnational Cannabis Ltd.
$0.00
Mkt Cap: $0.0B
USRM
U.S. Stem Cell, Inc.
$0.00
Mkt Cap: $0.0B
WRHLF
Love Hemp Group Plc
$0.00
Mkt Cap: $0.0B
Explore stocks similar to BRAXF for comparison